search icon
femy-img

Femasys Inc, Common Stock

FEMY

NAQ

$1.05

+$0

(0%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$24.04M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
59.19K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-2.83
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.73 L
$2.4 H
$1.05

About Femasys Inc, Common Stock

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameFEMYSectorS&P500
1-Week Return-4.55%0.31%-1.26%
1-Month Return-8.7%0.6%-4.16%
3-Month Return-7.08%-9.44%-0.46%
6-Month Return-6.25%-5.15%3.58%
1-Year Return11.35%0.33%22.47%
3-Year Return-66.77%4.53%25.13%
5-Year Return-91.25%35.98%77.7%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue929.06K1.04M1.18M1.21M1.07M[{"date":"2019-12-31","value":77.02,"profit":true},{"date":"2020-12-31","value":86.05,"profit":true},{"date":"2021-12-31","value":97.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.87,"profit":true}]
Cost of Revenue223.68K306.53K370.38K441.94K380.07K[{"date":"2019-12-31","value":50.61,"profit":true},{"date":"2020-12-31","value":69.36,"profit":true},{"date":"2021-12-31","value":83.81,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":86,"profit":true}]
Gross Profit705.39K731.38K809.30K764.28K691.90K[{"date":"2019-12-31","value":87.16,"profit":true},{"date":"2020-12-31","value":90.37,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.44,"profit":true},{"date":"2023-12-31","value":85.49,"profit":true}]
Gross Margin75.92%70.47%68.60%63.36%64.54%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":92.81,"profit":true},{"date":"2021-12-31","value":90.36,"profit":true},{"date":"2022-12-31","value":83.45,"profit":true},{"date":"2023-12-31","value":85.01,"profit":true}]
Operating Expenses12.34M7.66M9.15M12.36M15.20M[{"date":"2019-12-31","value":81.2,"profit":true},{"date":"2020-12-31","value":50.42,"profit":true},{"date":"2021-12-31","value":60.17,"profit":true},{"date":"2022-12-31","value":81.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(11.64M)(6.93M)(8.34M)(11.60M)(14.51M)[{"date":"2019-12-31","value":-1163718400,"profit":false},{"date":"2020-12-31","value":-693314300,"profit":false},{"date":"2021-12-31","value":-833680400,"profit":false},{"date":"2022-12-31","value":-1160026400,"profit":false},{"date":"2023-12-31","value":-1450841500,"profit":false}]
Total Non-Operating Income/Expense645.81K29.90K787.50K427.09K602.61K[{"date":"2019-12-31","value":82.01,"profit":true},{"date":"2020-12-31","value":3.8,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":54.23,"profit":true},{"date":"2023-12-31","value":76.52,"profit":true}]
Pre-Tax Income(11.27M)(6.91M)(7.53M)(11.39M)(14.24M)[{"date":"2019-12-31","value":-1126894200,"profit":false},{"date":"2020-12-31","value":-691319200,"profit":false},{"date":"2021-12-31","value":-753384500,"profit":false},{"date":"2022-12-31","value":-1138787000,"profit":false},{"date":"2023-12-31","value":-1424278600,"profit":false}]
Income Taxes3.01K1.80K4.00K6.30K4.34K[{"date":"2019-12-31","value":47.71,"profit":true},{"date":"2020-12-31","value":28.57,"profit":true},{"date":"2021-12-31","value":63.49,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":68.86,"profit":true}]
Income After Taxes(11.27M)(6.91M)(7.54M)(11.39M)(14.25M)[{"date":"2019-12-31","value":-1127194800,"profit":false},{"date":"2020-12-31","value":-691499200,"profit":false},{"date":"2021-12-31","value":-753784500,"profit":false},{"date":"2022-12-31","value":-1139417000,"profit":false},{"date":"2023-12-31","value":-1424712400,"profit":false}]
Income From Continuous Operations(11.27M)(6.91M)(7.54M)(11.39M)(12.73M)[{"date":"2019-12-31","value":-1127194800,"profit":false},{"date":"2020-12-31","value":-691499200,"profit":false},{"date":"2021-12-31","value":-753784500,"profit":false},{"date":"2022-12-31","value":-1139417000,"profit":false},{"date":"2023-12-31","value":-1273086600,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(11.27M)(6.91M)(7.54M)(11.39M)(14.25M)[{"date":"2019-12-31","value":-1127194800,"profit":false},{"date":"2020-12-31","value":-691499200,"profit":false},{"date":"2021-12-31","value":-753784500,"profit":false},{"date":"2022-12-31","value":-1139417000,"profit":false},{"date":"2023-12-31","value":-1424712400,"profit":false}]
EPS (Diluted)(2.30)(4.00)(1.05)(0.96)(0.92)[{"date":"2019-12-31","value":-230.48,"profit":false},{"date":"2020-12-31","value":-399.61,"profit":false},{"date":"2021-12-31","value":-105,"profit":false},{"date":"2022-12-31","value":-96,"profit":false},{"date":"2023-12-31","value":-92,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

FEMY
Cash Ratio 2.65
Current Ratio 3.94
Quick Ratio 3.26

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

FEMY
ROA (LTM) -59.54%
ROE (LTM) -138.37%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

FEMY
Debt Ratio Lower is generally better. Negative is bad. 0.62
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.38

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

FEMY
Trailing PE NM
Forward PE NM
P/S (TTM) 25.31
P/B 4.03
Price/FCF NM
EV/R 18.78
EV/Ebitda 0.24

FAQs

What is Femasys Inc share price today?

Femasys Inc (FEMY) share price today is $1.05

Can Indians buy Femasys Inc shares?

Yes, Indians can buy shares of Femasys Inc (FEMY) on Vested. To buy Femasys Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in FEMY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Femasys Inc be purchased?

Yes, you can purchase fractional shares of Femasys Inc (FEMY) via the Vested app. You can start investing in Femasys Inc (FEMY) with a minimum investment of $1.

How to invest in Femasys Inc shares from India?

You can invest in shares of Femasys Inc (FEMY) via Vested in three simple steps:

  • Click on Sign Up or Invest in FEMY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Femasys Inc shares
What is Femasys Inc 52-week high and low stock price?

The 52-week high price of Femasys Inc (FEMY) is $2.4. The 52-week low price of Femasys Inc (FEMY) is $0.73.

What is Femasys Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Femasys Inc (FEMY) is

What is Femasys Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Femasys Inc (FEMY) is 4.03

What is Femasys Inc dividend yield?

The dividend yield of Femasys Inc (FEMY) is 0.00%

What is the Market Cap of Femasys Inc?

The market capitalization of Femasys Inc (FEMY) is $24.04M

What is Femasys Inc’s stock symbol?

The stock symbol (or ticker) of Femasys Inc is FEMY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top